Voy
PrivateLast Round
Debt
Nov 1, 2025
Total Funding Raised
$472M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Voy is a digital health company that provides science-led treatments for weight loss, menopause, hair loss, and testosterone.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, D2C Brands, Subscription Commerce, Patient Engagement
Business Model
B2C
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Voy Comparables
Compare Voy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Manual | 94% | |
| Numan | 86% | |
| Wellster Healthtech Group | 85% |
For institutional investors. Book with your work email.
Voy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Nov 1, 2025 | ||||
| Debt | Nov 1, 2024 | ||||
| Series B | Oct 1, 2024 | ||||
| Series A | Mar 30, 2021 | ||||
| Seed | Jan 15, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Voy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GISEV | Series A |
| CASSIUS | Seed |
| Waldencast | Series A |
| Felix Capital | Seed, Series B, Series A |
| General Catalyst | Debt |
| FJ Labs | Series A |
| Sonoma Brands Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 21, 2026
Launched 'Do Health' as an independent startup.
- Oct 21, 2026
Product co-founded with Dr. Rangan Chatterjee.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_issues_withNov 5, 2026
On Nov 5th '26, the ASA upholds a complaint against Voy's video-on-demand advert, ruling that it promotes prescription-only medicines to the public; the advert must not appear again in the complained-of form.
For institutional investors. Book with your work email.
Voy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Voy's valuation, stock price, and market status.
Is Voy a public or private company?
Voy is a private company.
What is the current stock price of Voy?
Voy is a private company, so its shares have no public market price. Caplight tracks Voy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Voy worth (valuation)?
Valuation information for Voy is not publicly available.
Can I buy Voy stock?
Voy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Voy's last funding round?
Voy's most recent funding round was Debt on November 1, 2025.
Who are the main investors in Voy?
Key investors in Voy include Felix Capital, General Catalyst, Cherry Ventures.
Will Voy IPO soon?
No public IPO plans have been announced for Voy.
How can I track Voy secondary market activity?
Caplight tracks bids, offers, and trades in Voy's shares on secondary markets.